...
首页> 外文期刊>Journal of nephrology. >Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine.
【24h】

Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine.

机译:接受秋水仙碱和环孢霉素的肾脏移植患者的多器官功能衰竭。

获取原文
获取原文并翻译 | 示例
           

摘要

Colchicine is a relatively safe and effective medication when given at appropriate doses to patients with normal kidney and liver function. A clinical picture of multiple organ failure has been described in cases of colchicine poisoning and in kidney graft recipients treated with usual doses of colchicine during cyclosporine therapy. We report a case of multiple organ failure in a renal transplant patient who received appropriate doses of colchicine in combination with cyclosporine therapy. Interaction between colchicine and cyclosporine is postulated but boosting of CSA toxicity was excluded because of the low CSA blood through levels before and throughout the episode, in the presence of relatively stable renal function and for the prompt CSA withdrawal. Mechanism of toxicity and modulation of the P-glycoprotein by cyclosporine are reviewed. Although the proscription of the drug in cyclosporine-treated patients is not justified, caution is recommended in prescribing colchicine to patients receiving cyclosporine therapy, particularly in the presence of suboptimal kidney graft function.
机译:当肾和肝功能正常的患者以适当剂量服用时,秋水仙碱是一种相对安全有效的药物。在秋水仙碱中毒的情况下,以及在环孢霉素治疗期间接受常规剂量秋水仙碱治疗的肾移植受者中,已经描述了多器官衰竭的临床表现。我们报道了一名肾移植患者多器官功能衰竭的案例,该患者接受了适当剂量的秋水仙碱联合环孢素治疗。秋水仙碱和环孢菌素之间的相互作用被假定,但是由于在事件发生之前和整个过程中,通过较低水平的CSA血液,存在相对稳定的肾功能,并且由于CSA迅速撤出,CSA毒性的增强被排除在外。综述了环孢霉素的毒性机理和对P-糖蛋白的调节作用。尽管在环孢菌素治疗的患者中禁用该药物是不合理的,但建议在接受环孢素治疗的患者处方秋水仙碱时要特别谨慎,尤其是在肾移植功能不佳的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号